$BDSX News

Canaccord Genuity Maintains Buy on Biodesix, Raises Price Target to $35

HC Wainwright & Co. Maintains Buy on Biodesix, Raises Price Target to $27

Biodesix, Inc. (BDSX) Q2 2026 Earnings Call Transcript

Biodesix (NASDAQ:BDSX) Q2 EPS Beats, Revenue In Line, Shares Slip

Biodesix Affirms FY2026 Sales Guidance of $108.000M-$114.000M vs $110.996M Est

Roth Capital Initiates Coverage On Biodesix with Buy Rating, Announces Price Target of $32

Canaccord Genuity Maintains Buy on Biodesix, Raises Price Target to $27

HC Wainwright & Co. Initiates Coverage On Biodesix with Buy Rating, Announces Price Target of $26

Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade

Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue Assumptions

Biodesix to Participate in Upcoming Investor Conferences

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?

Canaccord Genuity Maintains Buy on Biodesix, Raises Price Target to $22

Biodesix, Inc. Q1 2026 Earnings Call Summary

Biodesix (BDSX) Q1 2026 Earnings Transcript

Biodesix Q1 Earnings Call Highlights

Biodesix BDSX Q2 2025 Earnings Call Transcript

Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates

Biodesix Inc (NASDAQ:BDSX) Q1 Results Smash Estimates, Shares Jump on Raised Guidance